Portal de investigación
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Charlton, M
- Levitsky, J
- Aqel, B
- O'Grady, J
- Hemibach, J
- Rinella, M
- Fung, J
- Ghabril, M
- Thomason, R
- Burra, P
- Little, EC
- Shaked, A
- Trotter, J
- Roberts, J
- Rodriguez-Davalos, M
- Rela, M
- Pomfret, E
- Heyrend, C
- Gallegos-Orozco, J
- Saliba, F
Grupos
Abstract
Effective immunosupression management is central to achieving optimal outcomes in liver transplant recipients. Current immunosuppression regimens and agents are highly effective in minimizing graft loss due to acute and chronic rejection but can also produce a substantial array of toxicities. The utilization of immunosuppression varies widely, contributing to the wide disparities in posttransplant outcomes reported between transplant centers. The International Liver Transplantation Society (ILTS) convened a consensus conference, comprised of a global panel of expert hepatologists, transplant surgeons, nephrologists, and pharmacologists to review the literature and experience pertaining to immunosuppression management to develop guidelines on key aspects of immunosuppression. The consensus findings and recommendations of the ILTS Consensus guidelines on immunosuppression in liver transplant recipients are presented in this article.
Datos de la publicación
- ISSN/ISSNe:
- 0041-1337, 1534-6080
- Tipo:
- Review
- Páginas:
- 727-743
- PubMed:
- 29485508
- Factor de Impacto:
- 1,904 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
TRANSPLANTATION LIPPINCOTT WILLIAMS & WILKINS
Citas Recibidas en Web of Science: 255
Documentos
- No hay documentos
Filiaciones
Keywords
- SIROLIMUS-BASED IMMUNOSUPPRESSION; ACUTE KIDNEY INJURY; ANTIBODY-MEDIATED REJECTION; STANDARD-DOSE TACROLIMUS; STEROID-FREE IMMUNOSUPPRESSION; PATIENTS RECEIVING EVEROLIMUS; ONSET DIABETES-MELLITUS; QUALITY-OF-LIFE; TERM-FOLLOW-UP; MYCOPHENOLATE-MOFETIL
Campos de Estudio
Cita
Charlton M,Levitsky J,Aqel B,O'Grady J,Hemibach J,Rinella M,Fung J,Ghabril M,Thomason R,Burra P,Little EC,Berenguer M,Shaked A,Trotter J,Roberts J,Rodriguez M,Rela M,Pomfret E,Heyrend C,Gallegos J,Saliba F. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation. 2018. 102(5):p. 727-743. IF:4,743. (1).